ACLF-AKI patients had significantly higher MT/Alb ratio compared to ACLF no-AKI patients (p-value ≤ 0.0001) as well as in ACLF patients who progressed to AKI vs those who did not (p-value ≤ 0.0001). This evidence concerns the gene ALB and acute kidney injury.